In neuroendocrine prostate cancer, the CREB/G-protein-coupled receptor kinase (GRK) 3 axis promotes neuroendocrine differentiation of the prostate cancer cells, whereas CREB activation is mediated by GRK3. This evidence concerns the gene GRK3 and prostate cancer.